Numerous studies have shown the ability of statins to reduce CRP blood levels (by about 15–30%) [72,73,74], while meta-analysis has shown that lipophilic statins are more effective in decreasing high-sensitivity CRP (hsCRP) and IL-6 in patients with HF [75]. Here, CRP is linked to hydrops fetalis.